Streamline and Grant Engine Launch Partnership to Transform Life Sciences Grant Writing
Wednesday, January 15, 2025
At Streamline, our mission has always been clear: unlock access to government funding to accelerate innovation and better the world. Today, we're thrilled to announce a partnership that brings powerful new capabilities to medical innovation: we're launching Grant Engine's Alpha. Grant Engine is the leader in biotech grant funding, with a track record of securing grants at 2-4 times the national average demonstrates the power of combining deep expertise with advanced technology.
Since launching with a focus on climate funding through the Inflation Reduction Act, we've seen firsthand how AI can transform the grant writing process. Our platform has helped climate tech companies, local governments, and community organizations navigate complex funding landscapes more efficiently. Now, we're bringing these same capabilities to life sciences, where the stakes for efficient funding access couldn't be higher.
Introducing Alpha: Transforming Life Sciences Grant Writing with AI
The biotech sector faces unique challenges in securing non-dilutive funding. The technical complexity of grant applications, combined with the urgent need to advance treatments to clinical trials, creates intense pressure on biotech companies. This is where Alpha becomes transformative. By combining Grant Engine's strategic expertise with Streamline's AI capabilities, we're offering a secure, efficient platform that helps life science companies navigate everything from large-scale grants to SBIR/STTR programs.
"Every hour reclaimed in grant writing is an opportunity for our clients to focus on life-saving innovation," says Sam C. Tetlow, founder and CEO of Grant Engine. "By combining Streamline's AI-powered precision technology with our strategic expertise we're not just saving time, we're giving our clients the necessary tools to win more funding with less pain."
Since 2015, Grant Engine has set the standard for excellence in life sciences grant funding. Built on durable and compelling advantages Grant Engine has a proven track record of winning essential funding for companies that have secured over a billion dollars in funding. Now, through Alpha, this expertise combines with Streamline's advanced AI technology to create an unprecedented product in the grant writing space.
Technology That Protects While It Empowers
Alpha isn't just about efficiency – it's about security and success. Our platform ensures the protection of your intellectual property while streamlining the grant writing process. It combines:
AI-powered compliance checks
Secure content development and storage
Strategic narrative optimization
Efficient adaptation of technical content
Expert guidance at every step
What excites us most about Alpha is its potential to remove traditional bottlenecks in biotech funding. By streamlining the process of securing funding from agencies like NIH, DOD, and NSF, we're helping transform how quickly companies can advance their research and development. Time saved in grant writing directly translates to accelerated development of treatments that could change lives.
Join the Future of Grant Writing
This partnership represents more than just a technological advancement in grant writing. It's about giving biotech innovators the tools they need to succeed in an increasingly competitive funding landscape. Through Alpha, we're combining the best of human expertise with AI efficiency to transform how innovation gets funded.
We're proud to partner with Grant Engine in this endeavor. Together, we're not just improving the grant writing process – we're helping accelerate the pace of medical breakthroughs that could change lives.
Get Started
Learn how Alpha can help secure the funding your innovation deserves by scheduling a time here.